Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Diabetes, obesity & metabolism; 2006 Nov;8(6):650-60. PMID: 17026489
Dallas Diabetes and Endocrine Center, Dallas, TX 75230, USA. juliorosenstock@dallasdiabetes.com
Category: